Petrylak DP, Tangen CM, Hussain MH, Lara PN Jr, Jones JA, Taplin ME, et al. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med. 2004;351:1513–20. https://doi.org/10.1056/NEJMoa041318.

Article  CAS  PubMed  Google Scholar 

Kantoff PW, Higano CS, Shore ND, Berger ER, Small EJ, Penson DF, et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med. 2010;363:411–22. https://doi.org/10.1056/NEJMoa1001294.

Article  CAS  PubMed  Google Scholar 

Le TK, Duong QH, Baylot V, Fargette C, Baboudjian M, Colleaux L, et al. Castration-resistant prostate cancer: from uncovered resistance mechanisms to current treatments. Cancers. 2023;15:5047. https://doi.org/10.3390/cancers15205047.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Garbar V, Richter S. Palliative radiation therapy for bone metastases. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024.

Mari A, Cadenar A, Giudici S, Cianchi G, Albisinni S, Autorino R, et al. Systematic review and meta-analysis to evaluate the diagnostic accuracy of PSMA PET/CT in the initial staging of prostate cancer. Prostate Cancer Prostatic Dis. 2024. https://doi.org/10.1038/s41391-024-00850-y.

Vanden Berg RNW, Zilli T, Achard V, Dorff T, Abern M. The diagnosis and treatment of castrate-sensitive oligometastatic prostate cancer: a review. Prostate Cancer Prostatic Dis. 2023;26:702–11. https://doi.org/10.1038/s41391-023-00688-w.

Article  CAS  PubMed  Google Scholar 

Doyle E, Killean AJ, Harrow S, Phillips ID. Systematic review of the efficacy of stereotactic ablative radiotherapy for oligoprogressive disease in metastatic cancer. Radiother Oncol. 2024;196:110288. https://doi.org/10.1016/j.radonc.2024.110288.

Le Gueveloua J, Cucciab F, Flippotc R, Ferrera G, Terlizzi M, Zilli T, et al. The current landscape of stereotactic body radiation therapy for metastatic castration-resistant prostate cancer. Prostate Cancer Prostatic Dis. 2024;19. https://doi.org/10.1038/s41391-024-00862-8.

Mitsogianni M, Papatsoris A, Bala VM, Issa H, Moussa M, Mitsogiannis I. An overview of hormonal directed pharmacotherapy for the treatment of prostate cancer. Expert Opin Pharmacother. 2023;24:1765–74. https://doi.org/10.1080/14656566.2023.2244415.

Article  CAS  PubMed  Google Scholar